Cell-Cell Communication Mapping Platform
Research tool for oncology, immunology, and other complex diseases
Development/Early AccessActive
Key Facts
Indication
Research tool for oncology, immunology, and other complex diseases
Phase
Development/Early Access
Status
Active
Company
About Moleculent
Moleculent is a private, pre-revenue platform company developing technology to map and analyze cell-cell communication in human tissue. Its core focus is on high-plex analysis of receptor-ligand interactions within the tissue context, aiming to provide unprecedented insights into disease mechanisms, particularly in immunology and oncology. The company is backed by notable venture capital firms and is positioning its platform as a tool to enable more effective drug development and personalized treatment strategies.
View full company profile